This story has been updated to include comments from a conference call discussing the company's earnings.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker reported a 19 percent spike in second-quarter revenues to $300.9 million.

The company's revenues for the three months ended June 30 compared to $252.5 million from the second quarter a year ago. Excluding the effects of acquisitions and foreign currency translation, revenues for the quarter were up 20 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.